Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Rhea-AI Summary
Clover Health (Nasdaq: CLOV) will report its fourth quarter and full year 2025 financial results after market close on Thursday, February 26, 2026, and host a webcast at 5:00 p.m. Eastern Time.
The webcast will be available live and archived for 12 months on Clover Health investor relations, and registration is available via the provided webcast link.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CLOV declined 1.32%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
CLOV was down 2.12% while peers were mixed: PGNY (+0.53%), ALHC (+2.27%), MOH (+3.95%), OSCR (-0.8%), NEUE (-0.69%). Moves do not indicate a unified sector direction.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 14 | MA growth update | Positive | +10.6% | Strong MA membership growth and outlook for 2026 GAAP profitability. |
| Jan 12 | Clinical impact data | Positive | +1.5% | AI-enabled platform metrics showing improved medical cost ratios and outcomes. |
| Dec 16 | Conference participation | Neutral | +0.8% | Announcement of presentation at J.P. Morgan 2026 Healthcare Conference. |
| Nov 17 | Conference participation | Neutral | +0.0% | Participation in the 2025 Citi Global Healthcare Conference. |
| Nov 04 | Q3 2025 earnings | Positive | -4.3% | Q3 results with strong revenue growth, raised guidance, but GAAP net loss. |
Recent fundamentally positive updates have generally coincided with positive price moves, while one earnings release saw a negative reaction.
Over the last few months, Clover reported strong operational momentum, including 53% Medicare Advantage membership growth to about 153,000 members and an expectation of first full-year GAAP net income profitability in 2026. Q3 2025 results showed $496.7M in revenue with raised full-year guidance despite a GAAP net loss. Other updates focused on conference participation and clinical impact from its AI platform. Today’s earnings date announcement follows this trajectory of operational and financial transparency.
Market Pulse Summary
This announcement schedules the release of Clover Health’s Q4 and full-year 2025 results for February 26, 2026, followed by a webcast. It follows recent updates on membership growth, improving profitability outlook, and prior earnings. Investors may focus on how upcoming results compare with earlier guidance and the company’s expectation of achieving first full-year GAAP net income profitability in 2026, as well as any revisions to membership and margin trends.
AI-generated analysis. Not financial advice.
WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Thursday, February 26, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter.
Fourth Quarter and Full Year 2025 Conference Webcast Details:
- What: Clover Health’s Fourth Quarter and Full Year 2025 Earnings Conference Call
- When: Thursday, February 26, 2026, at 5:00 p.m. Eastern Time
- Webcast: To access the webcast, you may register at https://clover-health-q425-earnings-call.open-exchange.net/.
A live and archived webcast of the conference call will also be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and in Underserved Populations as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
FAQ
When will Clover Health (CLOV) release Q4 and full year 2025 earnings and host the webcast?
How can investors access the Clover Health (CLOV) Q4 2025 earnings webcast?
Will Clover Health (CLOV) archive the Q4 and full year 2025 earnings webcast, and for how long?
What time is Clover Health's (CLOV) February 26, 2026 earnings conference call scheduled to start?
Will Clover Health (CLOV) discuss both quarterly and full year 2025 financial performance during the webcast?
